Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sovaldi
Biotech
J&J, tiny RNA biotech Arcturus combine for hepatitis B work
Johnson & Johnson has notched a deal with Arcturus Therapeutics to help with its new focus on hepatitis B.
Ben Adams
Oct 19, 2017 2:19pm
NuCana plans $115M IPO to test retooled chemotherapies
Sep 6, 2017 7:48am
Medivir sells Chinese rights to hepatitis C drug to Ascletis
Aug 18, 2017 8:30am
Newsummit Biopharma licenses hepatitis C antibody from charity group
Mar 15, 2017 12:49pm
AbbVie looks to battle Gilead with new hep C data
Apr 18, 2016 6:44am
